Neuroendocrine Tumors
2 competing products in clinical development for Neuroendocrine Tumors.
Pipeline by Phase
Phase 11
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lenvatinib | Eisai | Phase 2 | Completed | 35 |
| [212Pb] VMT-α-NET | Perspective Therapeutics | Phase 1 | Active | 27 |